Information about the 2019 Novel Coronavirus
Stem Cell-Derived Endothelial Cell function study
Looking for patients with early-onset hypertension (i.e. less than 40 years of age) in whom secondary causes have been ruled out clinically.
Patients may be taking anti-hypertensive medications. No restrictions on level of blood pressure or type of antihypertensive medications.
Patients would need to complete only one visit and a blood test (to obtain iPSCs for reprogramming to endothelial cells)
Contact us to find out if this trial is right for you.
Thu Vu, Research Coordinator
About this Clinical Trial
Your Message Will Go ToThu Vu, research coordinator
To:Thu Vu, research coordinator
Go Back To The Trial